Today: 20 May 2026
Ondas stock slips ahead of Friday Investor Day as $1 billion deal hangs over shares
15 January 2026
2 mins read

Ondas stock slips ahead of Friday Investor Day as $1 billion deal hangs over shares

New York, January 15, 2026, 15:02 EST — Regular session

  • Ondas shares dropped roughly 1% in afternoon trading, while volume surged.
  • This week, the company wrapped up a $1 billion stock-and-warrant deal, with shares priced at $16.45
  • Investors are focused on Friday’s Investor Day, eager for updates on the 2026 outlook, order trends, and M&A strategies

Ondas Holdings Inc shares dipped roughly 1.2% to $13.40 on Thursday, bouncing between $12.96 and $14.06 earlier in the session. Traders were reacting ahead of Friday’s investor day and digesting a recent sizable capital raise. More than 70 million shares had traded by mid-afternoon.

The dip matters as Ondas prepares to reveal how it plans to deploy nearly $1 billion in new capital — and whether demand for its drone and counter-drone equipment can support the influx of shares.

The question gained urgency after the company sold stock and warrants at a premium earlier this month. While this setup brings cash in fast, it also looms over the share count for some time.

Ondas announced Monday it closed a registered direct offering of 19 million shares along with pre-funded warrants for up to 41.79 million shares. Each share sold came with warrants to buy two additional shares. The company expects net proceeds around $959.2 million. If all warrants are exercised for cash, Ondas could pull in about $3.4 billion more, though it cautioned there’s no guarantee that will happen.

The deal came with a combined offering price of $16.45 per share-and-warrant package, roughly 17.5% above the January 8 close, the company said. Ondas shares closed about 19% below that price on Thursday, leaving a tricky gap investors often interpret as a dilution overhang.

A pre-funded warrant acts like a stand-in for a share: the bulk of the purchase price is paid upfront, followed by a small exercise price down the line. Buyers often use it to navigate ownership caps while maintaining economic exposure.

Stifel analyst Jonathan Siegmann, who bumped his price target to a Street-high $17, dismissed claims that Ondas is “just a hyped-up retail stock.” He pointed to the $1 billion institutional investment as clear evidence against that narrative, according to a TipRanks report published Thursday. TipRanks

Ondas will hold a virtual Ondas Autonomous Systems (OAS) investor day this Friday at 10:00 a.m. ET. The company is set to present an updated business plan and financial outlook through 2026, covering revenue-growth assumptions, capital allocation, and its strategy on partnerships and acquisitions. A Q&A session will follow.

In the defense-drone sector, stocks moved unevenly. AeroVironment slipped roughly 0.3%, while Kratos climbed near 2.9%, and Red Cat pushed up about 4.8%. ( | | )

But the setup works both ways. The warrants tied to the financing—and the chance of more shares hitting the market if exercised—could limit near-term gains. Any slip in guidance, order updates, or execution comments on Friday might escalate a typical pullback into a more pronounced sell-off.

Traders are gearing up for the investor day on January 16. They’ll be looking for any 2026 outlook ranges, updates on new customer wins or order momentum, and how management plans to approach acquisitions now that cash is available.

Stock Market Today

  • 3 Strategies to Profit from Lloyds Banking Group Shares
    May 20, 2026, 2:21 AM EDT. Lloyds Banking Group shares have rebounded strongly since their 2020 lows, reaching levels not seen since the 2007-09 financial crisis. Investors can profit through capital gains, with shares rising over 120% since mid-2022 for some, dividends yielding 3.8% annually-above the FTSE 100 average-and dividend reinvestment plans (DRIPs) which reinvest payouts to grow holdings further. This mix of share price appreciation, growing dividend payouts, and compounding via DRIPs offers multiple income streams amidst recent market volatility.

Latest articles

Wall Street Hit by Yield Jolt With Nvidia Up Next

Wall Street Hit by Yield Jolt With Nvidia Up Next

20 May 2026
U.S. stock ETFs remained lower late Tuesday after Wall Street’s main indexes fell for a third straight session, pressured by rising Treasury yields and caution ahead of Nvidia’s earnings. The SPDR S&P 500 ETF dropped 0.7% to $733.73. The 10-year Treasury yield hit 4.687%, its highest since January 2025, before easing. Nvidia shares slipped 0.7% after hours, with traders bracing for a major move post-earnings.
Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

20 May 2026
Viavi Solutions shares dropped 7.1% in after-hours trading Tuesday after the company announced a $500 million public stock offering aimed at repaying debt. The offering, unveiled just after the Nasdaq close, could add roughly 10.1 million new shares. Viavi plans to use proceeds to pay down a $450 million loan. Total debt would fall to $650 million, according to a preliminary SEC filing.
Analog Devices Shares Rally After $1.5B AI Power Deal Ahead of Earnings

Analog Devices Shares Rally After $1.5B AI Power Deal Ahead of Earnings

20 May 2026
Analog Devices agreed to acquire Empower Semiconductor for $1.5 billion in cash, sending ADI shares up 1.36% to $419.95 in after-hours trading after closing down 1.02%. The deal, approved by both boards, is expected to close in the second half of 2026 pending regulatory review. Empower CEO Tim Phillips will continue to lead integrated voltage regulator work after the merger.
Opendoor Technologies stock slips today as mortgage applications surge and Treasuries stay stubborn
Previous Story

Opendoor Technologies stock slips today as mortgage applications surge and Treasuries stay stubborn

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead
Next Story

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

Go toTop